These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 11205258
1. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines. Uefuji K, Ichikura T, Shinomiya N, Mochizuki H. Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258 [Abstract] [Full Text] [Related]
2. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Yamauchi T, Watanabe M, Hasegawa H, Nishibori H, Ishii Y, Tatematsu H, Yamamoto K, Kubota T, Kitajima M. Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220 [Abstract] [Full Text] [Related]
3. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells. Li HL, Zhang HW, Chen DD, Zhong L, Ren XD, St-Tu R. Acta Pharmacol Sin; 2002 Jul; 23(7):631-7. PubMed ID: 12100758 [Abstract] [Full Text] [Related]
4. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells. Nagahara T, Okano J, Murawaki Y. Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586 [Abstract] [Full Text] [Related]
5. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Elder DJ, Halton DE, Hague A, Paraskeva C. Clin Cancer Res; 1997 Oct; 3(10):1679-83. PubMed ID: 9815550 [Abstract] [Full Text] [Related]
6. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Tomozawa S, Nagawa H, Tsuno N, Hatano K, Osada T, Kitayama J, Sunami E, Nita ME, Ishihara S, Yano H, Tsuruo T, Shibata Y, Muto T. Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722 [Abstract] [Full Text] [Related]
7. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells. Cheng AS, Chan HL, Leung WK, Wong N, Johnson PJ, Sung JJ. Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783 [Abstract] [Full Text] [Related]
12. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest. Cheong E, Ivory K, Doleman J, Parker ML, Rhodes M, Johnson IT. Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531 [Abstract] [Full Text] [Related]
13. Growth inhibition of breast epithelial cells by celecoxib is associated with upregulation of insulin-like growth factor binding protein-3 expression. Levitt RJ, Buckley J, Blouin MJ, Schaub B, Triche TJ, Pollak M. Biochem Biophys Res Commun; 2004 Apr 02; 316(2):421-8. PubMed ID: 15020235 [Abstract] [Full Text] [Related]
14. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib. Zhang GS, Liu DS, Dai CW, Li RJ. Am J Hematol; 2006 Apr 02; 81(4):242-55. PubMed ID: 16550520 [Abstract] [Full Text] [Related]
15. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells. Sun Y, Tang XM, Half E, Kuo MT, Sinicrope FA. Cancer Res; 2002 Nov 01; 62(21):6323-8. PubMed ID: 12414664 [Abstract] [Full Text] [Related]
17. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Bottone FG, Martinez JM, Alston-Mills B, Eling TE. Carcinogenesis; 2004 Mar 01; 25(3):349-57. PubMed ID: 14633654 [Abstract] [Full Text] [Related]